Emerson forms life sciences executive board to advance one-click technology transfer initiative

Fujifilm diosynth biotechnologies, merck and pfizer to help emerson develop standards for holistic digitalized recipe platform to increase speed to market for life-saving drugs emerson's new life science technology transfer and software research center  to develop, verify technology austin, texas , oct. 4, 2023 /prnewswire/ -- global technology and software leader emerson (nyse: emr) announced a new executive board of key life sciences leaders to help define, review and demonstrate prototypes for emerson technologies that will safely speed life-saving drugs to market. collaborating through emerson's one-click technology transfer™ board, emerson customers fujifilm diosynth biotechnologies, merck and pfizer will lead the development of strategies, solutions and guidelines to convert today's life sciences manufacturing recipe transfer process into a digitalized production platform.
EMR Ratings Summary
EMR Quant Ranking